Please use this identifier to cite or link to this item: http://nopr.niscpr.res.in/handle/123456789/61413
Full metadata record
DC FieldValueLanguage
dc.contributor.authorEanti, Anjaneyulu-
dc.contributor.authorKuncha, Madhusudana-
dc.contributor.authorArundha, Ande-
dc.contributor.authorMisra, Sunil-
dc.contributor.authorVidavalur, Siddaiah-
dc.contributor.authorRamakrishna, Sistla-
dc.contributor.authorKanjilala, Sanjit-
dc.date.accessioned2023-02-21T10:19:41Z-
dc.date.available2023-02-21T10:19:41Z-
dc.date.issued2023-02-
dc.identifier.issn2583-1321 (Online); 0019-5103 (Print)-
dc.identifier.urihttp://nopr.niscpr.res.in/handle/123456789/61413-
dc.description115-120en_US
dc.description.abstractDifferent lipidic moieties such as 10-undecenoic, oleic, lipoic, caproic, caprylic and lauric acids have been acylated to demethylated karanjin to prepare six lipoconjugated karanjin. All the derivatives have been evaluated for antimicrobial, anticancer and antiinflammatory activities and compared with karanjin and its demethylated analog. Lipoconjugation does not seem to improve the activity of karanjin against studied bacterial and fungal strains. However, karanjin, demethylated karanjin and six lipoconjugated karanjin show moderate to good anticancer activity against prostate and breast cancer cell lines. Mild antiinflammatory response has also been observed in case of karanjin and lipoic acid-conjugated karanjin.en_US
dc.language.isoenen_US
dc.publisherNIScPR-CSIR, Indiaen_US
dc.sourceIJC Vol.62(02) [Feb 2023]en_US
dc.subjectSynthesisen_US
dc.subjectKaranjinen_US
dc.subjectLipoconjugated karanjinen_US
dc.subjectAnticanceren_US
dc.subjectAnti-inflammatoryen_US
dc.subjectAntimicrobial activityen_US
dc.titleSynthesis and bio-evaluation of novel acyl derivatives of karanjinen_US
dc.typeArticleen_US
dc.identifier.doihttps://doi.org/10.56042/ijc.v62i2.66256en_US
Appears in Collections:IJC Vol.62(02) [Feb 2023]

Files in This Item:
File Description SizeFormat 
IJC_62 (02) 115-120.pdf1.35 MBAdobe PDFView/Open
IJC 62 (02) 115-120_Supp. Info.pdf734.62 kBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.